Advanced search
Publication Cover
Acta Orthopaedica Volume 86, 2015 - Issue 6
Journal homepage
630
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Local delivery of a selective androgen receptor modulator failed as an anabolic agent in a rat bone marrow ablation model

Hannu T AroOrthopaedic Research Unit, Department of Orthopaedic Surgery and Traumatology, University of Turku and Turku University Hospital, Turku;Turku University Hospital, Turku, FinlandCorrespondence[email protected]
,
Julia KulkovaOrthopaedic Research Unit, Department of Orthopaedic Surgery and Traumatology, University of Turku and Turku University Hospital, TurkuCorrespondence[email protected]
,
Niko MoritzOrthopaedic Research Unit, Department of Orthopaedic Surgery and Traumatology, University of Turku and Turku University Hospital, Turku;Turku Clinical Biomaterials Centre, Institute of Dentistry, University of Turku, TurkuCorrespondence[email protected]
,
Esa KähkönenTurku University Hospital, Turku, FinlandCorrespondence[email protected]
&
Riina H MattilaOrthopaedic Research Unit, Department of Orthopaedic Surgery and Traumatology, University of Turku and Turku University Hospital, TurkuCorrespondence[email protected]
Pages 751-759 | Received 10 Jan 2015, Accepted 21 May 2015, Published online: 22 Jul 2015

  • Abu EO, Horner A, Kusec V, Triffitt JT, Compston JE. The localization of androgen receptors in human bone. J Clin Endocrinol Metab 1997; 82 (10): 3493–7.
  • Alm JJ, Koivu HM, Heino TJ, Hentunen TA, Laitinen S, Aro HT. Circulating plastic adherent mesenchymal stem cells in aged hip fracture patients. J Orthop Res 2010; 28 (12): 1634–42.
  • Aro HT, Govender S, Patel AD, Hernigou P, Perera de Gregorio A, Popescu GI, Golden JD, Christensen J, Valentin A. Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation. J Bone Joint Surg (Am) 2011; 93 (9): 801–8.
  • Bais MV, Wigner N, Young M, Toholka R, Graves DT, Morgan EF, Gerstenfeld LC, Einhorn TA. BMP2 is essential for post natal osteogenesis but not for recruitment of osteogenic stem cells. Bone 2009; 45 (2): 254–66.
  • Bellido T, Jilka RL, Boyce BF, Girasole G, Broxmeyer H, Dalrymple SA, Murray R, Manolagas SC. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J Clin Invest 1995; 95 (6): 2886–95.
  • Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Müller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 2010; 25 (7): 1468–86.
  • Clarke BL, Khosla S. Androgens and bone. Steroids 2009; 74 (3): 296–305.
  • Daculsi G, Goyenvalle E, Cognet R, Aguado E, Suokas EO. Osteoconductive properties of poly(96L/4D-lactide)/beta-tricalcium phosphate in long term animal model. Biomaterials 2011; 32 (12): 3166–77.
  • Gao W, Reiser PJ, Coss CC, Phelps MA, Kearbey JD, Miller DD, Dalton JT. Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats. Endocrinology 2005; 146 (11): 4887–97.
  • Gori F, Hofbauer LC, Dunstan CR, Spelsberg TC, Khosla S, Riggs BL. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal- osteoblast lineage cells is developmentally regulated. Endocrinology 2000; 141 (12): 4768–76.
  • Hatano H, Siegel HJ, Yamagiwa H, Bronk JT, Turner RT, Bolander ME, Sarkar G. Identification of estrogen-regulated genes during fracture healing, using DNA microarray. J Bone Miner Metab 2004; 22 (3): 224–35.
  • Hunziker EB, Enggist L, Küffer A, Buser D, Liu Y. Osseointegration: the slow delivery of BMP-2 enhances osteoinductivity. Bone 2012; 51 (1): 98–106.
  • Kawano H, Sato T, Yamada T, Matsumoto T, Sekine K, Watanabe T, Nakamura T, Fukuda T, Yoshimura K, Yoshizawa T, Aihara K, Yamamoto Y, Nakamichi Y, Metzger D, Chambon P, Nakamura K, Kawaguchi H, Kato S. Suppressive function of androgen receptor in bone resorption. Proc Natl Acad Sci USA 2003; 100 (16): 9416–21.
  • Kearbey JD, Gao W, Narayanan R, Fisher SJ, Wu D, Miller DD, Dalton JT. Selective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats. Pharm Res 2007; 24 (2): 328–35.
  • Kearbey JD, Gao W, Fisher SJ, Wu D, Miller DD, Dalton JT. Effects of selective androgen receptor modulator (SARM) treatment in osteopenic female rats. Pharm Res 2009; 26 (11): 2471–7.
  • Kim HK, Oxendine I, Kamiya N. High-concentration of BMP2 reduces cell proliferation and increases apoptosis via DKK1 and SOST in human primary periosteal cells. Bone 2013; 54 (1): 141–50.
  • Komm BS, Mirkin S. An overview of current and emerging SERMs. J Steroid Biochem Mol Biol 2014; 143C: 207–22.
  • Mohler ML, Bohl CE, Jones A, Coss CC, Narayanan R, He Y, Hwang DJ, Dalton JT, Miller DD. Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit. J Med Chem 2009; 52 (12): 3597–617.
  • Pederson L, Kremer M, Judd J, Pascoe D, Spelsberg TC, Riggs BL, Oursler MJ. Androgens regulate bone resorption activity of isolated osteoclasts in vitro. Proc Natl Acad Sci USA 1999; 96 (2): 505–10.
  • Pitt CG, Jeffcoat AR, Zweidinger RA, Schindler A. Sustained drug delivery systems. I. The permeability of poly(epsilon-caprolactone), poly(DL-lactic acid), and their copolymers. J Biomed Mater Res 1979; 13 (3): 497–507.
  • Seeherman HJ, Li XJ, Bouxsein ML, WozneyJM. rhBMP-2 induces transient bone resorption followed by bone formation in a nonhuman primate core-defect model. Bone Joint Surg (Am) 2010; 92 (2): 411–26.
  • Seeherman HJ, Li XJ, Smith E, WozneyJM. rhBMP-2/calcium phosphate matrix induces bone formation while limiting transient bone resorption in a nonhuman primate core defect model. Bone Joint Surg (Am) 2012; 94 (19): 1765–76.
  • Sinnesael M, Claessens F, Laurent M, Dubois V, Boonen S, Deboel L, Vanderschueren D. Androgen receptor (AR) in osteocytes is important for the maintenance of male skeletalintegrity: evidence from targeted AR disruption in mouse osteocytes. J Bone Miner Res 2012; 27 (12): 2535–43.
  • Suva LJ, Seedor JG, Endo N, Quartuccio HA, Thompson DD, Bab I, Rodan GA. Pattern of gene expression following rat tibial marrow ablation. J Bone Miner Res 1993; 8 (3): 379–88.
  • Vajda EG, Hogue A, Griffiths KN, Chang WY, Burnett K, Chen Y, Marschke K, Mais DE, Pedram B, Shen Y, van Oeveren A, Zhi L, López FJ, Meglasson MD. Combination treatment with a selective androgen receptor modulator q(SARM) and a bisphosphonate has additive effects in osteopenic female rats. J Bone Miner Res 2009; 24 (2): 231–40.
  • Van der Eerden BC, van Til NP, Brinkmann AO, Lowik CW, Wit JM, Karperien M. Gender differences in expression of androgen receptor in tibial growth plate and metaphyseal bone of the rat. Bone 2002; 30 (6): 891–6.
  • Vanderschueren D, Laurent MR, Claessens F, Gielen E, Lagerquist MK, Vandenput L, Börjesson AE, Ohlsson C. Sex steroid actions in male bone. Endocr Rev 2014; 35 (6): 906–60.
  • Venken K, De Gendt K, Boonen S, Ophoff J, Bouillon R, Swinnen JV, Verhoeven G, Vanderschueren D. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model. J Bone Miner Res 2006; 21 (4): 576–85.
  • Wiren KM, Chapman Evans A, Zhang XW. Osteoblast differentiation influences androgen and estrogen receptor-alpha and -beta expression. J Endocrinol 2002; 175 (3): 683–94.
  • Wiren KM, Zhang XW, Toombs AR, Kasparcova V, Gentile MA, Harada S, Jepsen KJ. Targeted overexpression of androgen receptor in osteoblasts: unexpected complex bone phenotype in growing animals. Endocrinology 2004; 145 (7): 3507–22.
  • Wiren KM, Semirale AA, Zhang XW, Woo A, Tommasini SM, Price C, Schaffler MB, Jepsen KJ. Targeting of androgen receptor in bone reveals a lack of androgen anabolic action and inhibition of osteogenesis: a model for compartment-specific androgen action in the skeleton. Bone 2008; 43 (3): 440–51.
  • Wiren KM, Semirale AA, Hashimoto JG, Zhang XW. Signaling pathways implicated in androgen regulation of endocortical bone. Bone 2010; 46 (3): 710–23.
  • Wiren KM, Hashimoto JG, Semirale AA, Zhang XW. Bone vs. fat: embryonic origin of progenitors determines response to androgen in adipocytes and osteoblasts. Bone 2011; 49 (4): 662–72.
  • Välimäki VV, Moritz N, Yrjans JJ, Vuorio E, Aro HT. Effect of zoledronic acid on incorporation of a bioceramic bone graft substitute. Bone 2006; 38 (3): 432–43.
  • Yeh S, Tsai M, Xu Q, Mu X, Lardy H, Huang KE, Lin H, Yeh SD, Altuwaijri S, Zhou X, Xing L, Boyce BF, Hung MC, Zhang S, Gan L, Chang C. Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA 2002; 99 (21): 13498–503.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.